Rx Hydroquinone Skin Bleach Regulatory Controls Sought By Galderma
This article was originally published in The Rose Sheet
Executive Summary
Galderma Labs calls for stricter FDA enforcement over unapproved marketed prescription drugs and new requirements for disclosure regarding the lack of approval in recent comments to the agency